持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 3,835 | 3,850 | 3,725 | 3,735 | -135 | -3.5% | 56,200 |
| 2022/03/30 | 3,995 | 3,995 | 3,835 | 3,870 | -120 | -3% | 55,700 |
| 2022/03/29 | 3,995 | 4,000 | 3,925 | 3,990 | +45 | +1.1% | 52,800 |
| 2022/03/28 | 3,975 | 3,990 | 3,930 | 3,945 | +10 | +0.3% | 39,400 |
| 2022/03/25 | 3,920 | 3,985 | 3,920 | 3,935 | -30 | -0.8% | 29,600 |
| 2022/03/24 | 3,955 | 3,965 | 3,905 | 3,965 | -10 | -0.3% | 28,200 |
| 2022/03/23 | 3,895 | 3,990 | 3,895 | 3,975 | +85 | +2.2% | 42,000 |
| 2022/03/22 | 3,980 | 3,980 | 3,880 | 3,890 | -40 | -1% | 44,700 |
| 2022/03/18 | 3,955 | 3,975 | 3,905 | 3,930 | -25 | -0.6% | 76,800 |
| 2022/03/17 | 3,945 | 3,985 | 3,935 | 3,955 | +25 | +0.6% | 49,900 |
| 2022/03/16 | 3,925 | 3,975 | 3,920 | 3,930 | +5 | +0.1% | 50,500 |
| 2022/03/15 | 3,870 | 3,945 | 3,855 | 3,925 | +65 | +1.7% | 50,400 |
| 2022/03/14 | 3,890 | 3,900 | 3,860 | 3,860 | ±0 | ±0% | 36,500 |
| 2022/03/11 | 3,850 | 3,895 | 3,835 | 3,860 | -25 | -0.6% | 57,900 |
| 2022/03/10 | 3,765 | 3,890 | 3,765 | 3,885 | +155 | +4.2% | 51,100 |
| 2022/03/09 | 3,755 | 3,775 | 3,720 | 3,730 | -40 | -1.1% | 52,800 |
| 2022/03/08 | 3,800 | 3,835 | 3,755 | 3,770 | +40 | +1.1% | 71,400 |
| 2022/03/07 | 3,745 | 3,780 | 3,710 | 3,730 | -15 | -0.4% | 41,500 |
| 2022/03/04 | 3,800 | 3,835 | 3,745 | 3,745 | -55 | -1.4% | 42,000 |
| 2022/03/03 | 3,755 | 3,850 | 3,755 | 3,800 | +45 | +1.2% | 41,000 |
| 2022/03/02 | 3,790 | 3,825 | 3,755 | 3,755 | -85 | -2.2% | 35,600 |
| 2022/03/01 | 3,840 | 3,895 | 3,820 | 3,840 | ±0 | ±0% | 46,700 |
| 2022/02/28 | 3,755 | 3,850 | 3,755 | 3,840 | +105 | +2.8% | 62,500 |
| 2022/02/25 | 3,800 | 3,825 | 3,725 | 3,735 | -75 | -2% | 45,700 |
| 2022/02/24 | 3,805 | 3,820 | 3,775 | 3,810 | +5 | +0.1% | 74,300 |
| 2022/02/22 | 3,840 | 3,855 | 3,785 | 3,805 | -80 | -2.1% | 40,600 |
| 2022/02/21 | 3,855 | 3,890 | 3,835 | 3,885 | +15 | +0.4% | 32,800 |
| 2022/02/18 | 3,805 | 3,885 | 3,800 | 3,870 | +35 | +0.9% | 31,800 |
| 2022/02/17 | 3,860 | 3,880 | 3,835 | 3,835 | -30 | -0.8% | 34,300 |
| 2022/02/16 | 3,840 | 3,875 | 3,830 | 3,865 | +30 | +0.8% | 35,700 |
| 2022/02/15 | 3,820 | 3,875 | 3,815 | 3,835 | +50 | +1.3% | 71,100 |
| 2022/02/14 | 3,730 | 3,805 | 3,710 | 3,785 | -5 | -0.1% | 45,700 |
| 2022/02/10 | 3,780 | 3,790 | 3,750 | 3,790 | ±0 | ±0% | 37,400 |
| 2022/02/09 | 3,770 | 3,810 | 3,760 | 3,790 | +30 | +0.8% | 54,700 |
| 2022/02/08 | 3,695 | 3,780 | 3,695 | 3,760 | +40 | +1.1% | 48,400 |
| 2022/02/07 | 3,630 | 3,725 | 3,630 | 3,720 | +80 | +2.2% | 47,700 |
| 2022/02/04 | 3,650 | 3,685 | 3,630 | 3,640 | -40 | -1.1% | 51,600 |
| 2022/02/03 | 3,650 | 3,715 | 3,650 | 3,680 | +25 | +0.7% | 40,600 |
| 2022/02/02 | 3,650 | 3,690 | 3,630 | 3,655 | +5 | +0.1% | 60,800 |
| 2022/02/01 | 3,560 | 3,680 | 3,560 | 3,650 | +90 | +2.5% | 81,100 |
| 2022/01/31 | 3,485 | 3,580 | 3,475 | 3,560 | +75 | +2.2% | 63,200 |
| 2022/01/28 | 3,435 | 3,525 | 3,435 | 3,485 | +85 | +2.5% | 32,600 |
| 2022/01/27 | 3,505 | 3,505 | 3,385 | 3,400 | -110 | -3.1% | 60,100 |
| 2022/01/26 | 3,550 | 3,550 | 3,510 | 3,510 | ±0 | ±0% | 26,000 |
| 2022/01/25 | 3,510 | 3,510 | 3,465 | 3,510 | -40 | -1.1% | 30,800 |
| 2022/01/24 | 3,445 | 3,550 | 3,445 | 3,550 | +60 | +1.7% | 36,500 |
| 2022/01/21 | 3,450 | 3,510 | 3,440 | 3,490 | +45 | +1.3% | 32,400 |
| 2022/01/20 | 3,360 | 3,485 | 3,360 | 3,445 | +75 | +2.2% | 33,800 |
| 2022/01/19 | 3,435 | 3,455 | 3,355 | 3,370 | -115 | -3.3% | 55,300 |
| 2022/01/18 | 3,580 | 3,580 | 3,485 | 3,485 | -85 | -2.4% | 45,900 |
651～
700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
